
Palisade Bio’s Cash Boost: SR&ED Tax Incentive Program Fuels Development of Ulcerative Colitis Treatment PALI-2108
Exciting Advancements in Pharmaceutical Research: PALI-2108 and the SR&ED Tax Credit In the ever-evolving world of pharmaceutical research, every breakthrough brings us one step closer to addressing some of the most pressing health concerns. One such promising development comes from Company, a trailblazing organization in the industry, and their co-development partner, Giiant Pharma, Inc. (Giiant)….